718-1250

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2013-09-21

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-29 (study day 100.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-29 (study day 100.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-12-29 (study day 100.0); relationship: PROBABLE

moderate assessed

Moderate BALANCE DISORDER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-09 (study day 19.0); relationship: POSSIBLE

mild assessed

Mild BALANCE DISORDER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-09 (study day 19.0); relationship: POSSIBLE

mild assessed

Mild BALANCE DISORDER — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 19.0); relationship: POSSIBLE

moderate assessed

Moderate CONTUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-15 (study day 25.0); relationship: REMOTE

mild assessed

Mild CONTUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-15 (study day 25.0); relationship: REMOTE

mild assessed

Mild CONTUSION — outcome: RECOVERED/RESOLVED; onset 2013-10-15 (study day 25.0); relationship: REMOTE

mild assessed

Mild COORDINATION ABNORMAL — outcome: RECOVERED/RESOLVED; onset 2013-11-15 (study day 56.0); relationship: POSSIBLE

mild assessed

Mild FALL — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 19.0); relationship: REMOTE

Data queries

No data queries.